PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Psychedelic use associated with lower odds of heart disease and diabetes, study finds

by Eric W. Dolan
October 11, 2021
Reading Time: 2 mins read

People who have tried a psychedelic drug at least once in their lifetime have lower odds of heart disease and diabetes, according to new research published in Scientific Reports. The new findings highlight the need for further research to investigate the link between psychedelics and cardiometabolic health.

“In our previous research, we have found associations between lifetime classic psychedelic use and lower odds of being overweight or obese as well as lower odds of having hypertension in the past year, both of which are risk factors of cardiometabolic disease,” said study author Otto Simonsson of the University of Oxford. “We therefore wanted to look specifically at the link between lifetime classic psychedelic use and cardiometabolic diseases such as diabetes and heart disease.”

In an article published in Journal of Psychopharmacology this year, researchers argued “that psychedelic substances such as psilocybin could be used to assist in promoting positive lifestyle change conducive to good overall health,” noting that the use of psychedelic drugs has been associated with spontaneous changes in health-related behaviors, such as reducing alcohol consumption and exercising more.

Simonsson and his colleagues noted in their current study that psychedelics have also “been shown to improve mental health conditions associated with cardiometabolic diseases” and to have some anti-inflammatory properties.

To examine the relationship between psychedelic use and physical health, the researchers examined data from more than 375,000 Americans who had participated in the National Survey on Drug Use and Health, an annual survey sponsored by the U.S. Department of Health and Human Services. Participants reported whether they had ever used the classic psychedelic substances DMT, ayahuasca, LSD, mescaline, peyote or San Pedro, or psilocybin. They also reported whether they had been diagnosed with heart disease or diabetes in the past year.

The researchers found that the prevalence of both conditions was lower among psychedelic users. Approximately 2.3% of those who had ever used a psychedelic reported heart disease in the past year, compared to 4.5% of those who reported never using a psychedelic drug. Similarly, 3.95% of those who had ever used a psychedelic reported diabetes in the past year, compared to 7.7% of those who reported never using a psychedelic drug.

“The findings suggest that lifetime classic psychedelic use is associated with lower odds of having had heart disease or diabetes in the past year,” Simonsson told PsyPost.

The researchers controlled for age, gender, marital status, race, annual household income, level of education, engagement in risky behavior, and the use of other types of drugs. But the findings come with an important caveat.

“The direction of causality remains unknown,” Simonsson said. “Future trials with double-blind, randomized, placebo-controlled designs are needed to establish whether classic psychedelic use may reduce the risk of cardiometabolic diseases and, if so, through which mechanisms.”

The study, “Associations between lifetime classic psychedelic use and cardiometabolic diseases“, was authored by Otto Simonsson, Walter Osika, Robin Carhart-Harris, and Peter S. Hendricks.

TweetSendScanShareSendPin2ShareShareShareShareShare

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • Women want to talk about sex with their close friends more often, study finds
  • Scientists uncover how a tiny reflection of light helps us navigate the social world
  • Over 10 percent of factual claims in Google’s AI search summaries aren’t backed by their cited sources, study finds
  • Inflammation briefly dampens pleasure and the desire to socialize, placebo-controlled study finds
  • Narcissistic parents tend to lean on their children for emotional support, and that is linked to depression later on

Science of Money

  • For male startup founders, average looks may pay off best in the pitch room, according to new Shark Tank study
  • Why struggling with bills feels even worse when you think the economy is booming
  • Feeling stuck in an unwanted work location takes a measurable toll on mental health
  • Why having a self-sacrificing boss can feel like a trap, according to psychology
  • News about shortages only triggers stockpiling when shoppers start searching online, study finds

Recent

  • Loving-kindness meditation fails to beat muscle relaxation for pain or social well-being in online trial
  • Losing childhood weight by adulthood might erase later depression risks
  • Women don’t find deeper-than-average voices more attractive when they can see the man
  • Voters value long-term economic growth more than previously thought, study finds
  • Scientists map a blood protein fingerprint of menopause tied to brain health
  • Social anxiety might not warp how we perceive eye contact
  • In female mice modeling schizophrenia, a single dose of psilocybin restored sensory filtering for days
  • Could psychedelics aid therapy for personality disorders? An unusual case offers a first look
  • Schizophrenia is linked to broad difficulty reading emotions from body language and faces
  • Socially isolated and lonely people tend to be biologically older than their years

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • FAQ

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc